New drug trial aims to control Tough-to-Treat blood cancer

NCT ID NCT02970318

Ongoing Disease control Sponsor: Acerta Pharma BV Source: ClinicalTrials.gov ↗

Summary

This study tested whether a newer drug, acalabrutinib, works better than standard drug combinations for adults whose chronic lymphocytic leukemia (CLL) has returned or stopped responding to prior treatment. It directly compared how long patients lived without their cancer getting worse on the different treatments. The goal was to find a more effective way to control this blood cancer over the long term.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Chandler, Arizona, 85224, United States
Research Site

Oxnard, California, 93030, United States
Research Site

Athens, Georgia, 30607, United States
Research Site

Joliet, Illinois, 60435, United States
Research Site

Cedar Rapids, Iowa, 52403, United States
Research Site

Mount Sterling, Kentucky, 40353, United States
Research Site

Saint Cloud, Minnesota, 56303, United States
Research Site

Lincoln, Nebraska, 68506, United States
Research Site

Brick, New Jersey, 08724, United States
Research Site

Nyack, New York, 10960, United States
Research Site

Canton, Ohio, 44719, United States
Research Site

Fort Sam Houston, Texas, 78234, United States
Research Site

Round Rock, Texas, 78665, United States
Research Site

Adelaide, 5000, Australia
Research Site

Box Hill, 3128, Australia
Research Site

Frankston, 3199, Australia
Research Site

Geelong, 3220, Australia
Research Site

Gosford, 2250, Australia
Research Site

Hobart, 7000, Australia
Research Site

Kogarah, 2217, Australia
Research Site

Murdoch, 6150, Australia
Research Site

Nedlands, 6009, Australia
Research Site

South Brisbane, 4101, Australia
Research Site

Woodville, 5011, Australia
Research Site

Linz, 4010, Austria
Research Site

Salzburg, 5020, Austria
Research Site

Vienna, 1130, Austria
Research Site

Vienna, 1160, Austria
Research Site

Wels, 4600, Austria
Research Site

Antwerp, 2060, Belgium
Research Site

Ghent, 9000, Belgium
Research Site

Roeselare, 8900, Belgium
Research Site

Yvoir, 5530, Belgium
Research Site

Pleven, 5800, Bulgaria
Research Site

Plovdiv, 4002, Bulgaria
Research Site

Stara Zagora, 6000, Bulgaria
Research Site

Vratsa, 3000, Bulgaria
Research Site

Barrie, Ontario, L4M 6M2, Canada
Research Site

Calgary, T2N 2T9, Canada
Research Site

Montreal, H3T 1E2, Canada
Research Site

Ottawa, K1H 8L6, Canada
Research Site

Regina, S4T 7T1, Canada
Research Site

Saint John, E2L 4L2, Canada
Research Site

Toronto, M4N 3M5, Canada
Research Site

Toronto, M5G 2M9, Canada
Research Site

Zadar, 23 000, Croatia
Research Site

Zagreb, 10 000, Croatia
Research Site

Brno, 625 00, Czechia
Research Site

Nový Hradec Králové, 500 05, Czechia
Research Site

Olomouc, 779 00, Czechia
Research Site

Ostrava Poruba, 708 52, Czechia
Research Site

Plzen - Lochotin, 304 60, Czechia
Research Site

Prague, 100 34, Czechia
Research Site

Bordeaux, 33076, FR, France
Research Site

Brest, 29609, France
Research Site

Montpellier, 34295, France
Research Site

Nantes, 44093, France
Research Site

Paris, 75010, France
Research Site

Paris, 75651, France
Research Site

Perpignan, 66000, France
Research Site

Provence Alpes Cote D'Azur, 13273, France
Research Site

Rennes, 35000, France
Research Site

Rouen, 76038, France
Research Site

Aschaffenburg, 63739, Germany
Research Site

Dresden, 1307, Germany
Research Site

Mutlangen, 73557, Germany
Research Site

München, 81377, Germany
Research Site

Ulm, 89081, Germany
Research Site

Hong Kong, 150001, Hong Kong
Research Site

Pok Fu Lam, Hong Kong
Research Site

Budapest, 1122, Hungary
Research Site

Debrecen, 4032, Hungary
Research Site

Gyula, 5700, Hungary
Research Site

Kaposvár, 7400, Hungary
Research Site

Ashkelon, 7830604, Israel
Research Site

Haifa, 34362, Israel
Research Site

Jerusalem, 9112001, Israel
Research Site

Kfar Saba, 4428164, Israel
Research Site

Nahariya, 22100, Israel
Research Site

Petah Tikvah, 49102, Israel
Research Site

Aviano, 33081, Italy
Research Site

Bergamo, 24127, Italy
Research Site

Brescia, 25123, Italy
Research Site

Florence, 50134, Italy
Research Site

Genova, 16126, Italy
Research Site

Genova, 16132, Italy
Research Site

Meldola, 47014, Italy
Research Site

Milan, 20132, Italy
Research Site

Milan, 20162, Italy
Research Site

Modena, 41100, Italy
Research Site

Addington, 8011, New Zealand
Research Site

Dunedin, 9016, New Zealand
Research Site

Palmerston North, 4442, New Zealand
Research Site

Tauranga, 3112, New Zealand
Research Site

Bialystok, 15-276, Poland
Research Site

Bydgoszcz, 85-168, Poland
Research Site

Gdansk, 80-129, Poland
Research Site

Krakow, 30-727, Poland
Research Site

Lodz, 93-510, Poland
Research Site

Lublin, 20-081, Poland
Research Site

Woj. Podkarpackie, 36-200, Poland
Research Site

Novosibirsk, 630087, Russia
Research Site

Obninsk, 249031, Russia
Research Site

Penza, 440008, Russia
Research Site

Ryazan, 390000, Russia
Research Site

Saint Petersburg, 194044, Russia
Research Site

Saint Petersburg, 197341, Russia
Research Site

Sochi, Unk, Russia
Research Site

Tula, 300053, Russia
Research Site

Volgograd, Unk, Russia
Research Site

Yaroslavl, 150023, Russia
Research Site

Yekaterinburg, 620072, Russia
Research Site

SGP, 169608, Singapore
Research Site

SGP, 188770, Singapore
Research Site

SGP, 217562, Singapore
Research Site

Bratislava, 833 10, Slovakia
Research Site

Košice, 040 01, Slovakia
Research Site

Busan, 49241, South Korea
Research Site

Daegu, 41944, South Korea
Research Site

Donggu, 44033, South Korea
Research Site

Gyeonggi-do, 13620, South Korea
Research Site

Incheon, UNK, South Korea
Research Site

Jeonju, 54907, South Korea
Research Site

Seoul, 3080, South Korea
Research Site

Seoul, 3722, South Korea
Research Site

Badalona, 8916, Spain
Research Site

Madrid, 28006, Spain
Research Site

Madrid, 28009, Spain
Research Site

Madrid, 28031, Spain
Research Site

Madrid, 28033, Spain
Research Site

Madrid, 28041, Spain
Research Site

Majadahonda, 28222, Spain
Research Site

Salamanca, 37007, Spain
Research Site

Santander, 39008, Spain
Research Site

Valencia, 46026, Spain
Research Site

Gothenburg, 413 46, Sweden
Research Site

Luleå, 97180, Sweden
Research Site

Stockholm, 171 76, Sweden
Research Site

Hualien City, 970, Taiwan
Research Site

Tainan, 70403, Taiwan
Research Site

Taipei, 100, Taiwan
Research Site

Cherkasy, 18009, Ukraine
Research Site

Dnipropetrovsk, 49102, Ukraine
Research Site

Ivano-Frankivsk, Ukraine
Research Site

Khmelnytsky, 29000, Ukraine
Research Site

Kyiv, 03022, Ukraine
Research Site

Kyiv, Ukraine
Research Site

Zhytomyr, 10002, Ukraine
Research Site

Birmingham, B9 5SS, United Kingdom
Research Site

Cambridge, CB2 0QQ, United Kingdom
Research Site

Canterbury, CT1 3NG, United Kingdom
Research Site

Leicester, LE1 7RH, United Kingdom
Research Site

London, SE5 9RS, United Kingdom
Research Site

Maidstone, ME16 9QQ, United Kingdom
Research Site

Manchester, M20 4BX, United Kingdom
Research Site

Southampton, SO16 6YD, United Kingdom
Research Site

Wolverhampton, WV10 0QP, United Kingdom

Conditions

Explore the condition pages connected to this study.

CHRONIC LYMPHOCYTIC LEUKEMIA